InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Gallagher Carol Giltner, Director. Insider active across 5 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 10 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €37k. Activity tracked since 8 June 2021. The latest transaction was filed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Gallagher Carol Giltner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
7,828 shares0Common StockSEC:0000905148-25-002142:0
150,000 shares0Common StockSEC:0000905148-24-001057:0
7,555 sharesCommon StockSEC:0001140361-24-003527:0
6,808 shares@ US$58.75100.0% of flowCommon StockSEC:0001628280-24-000312:0
179,020 shares@ US$0.2236100.0% of flowCommon StockSEC:0000905148-23-001457:0
Canonical exit: 11 Feb 2024 (T+90)
7,555 shares0Common StockSEC:0001628280-23-023351:0
57,000 shares0Common StockSEC:0001140361-23-028153:0
20,500 shares0Common StockSEC:0001140361-22-024166:0
7,059 shares0Common StockSEC:0001415889-21-003028:0
11,000 shares0Common StockSEC:0001140361-21-020437:0
10 of 10 declarations
About Gallagher Carol Giltner
Director, Carol Giltner Gallagher has filed 10 disclosures in total. In the 10 recent filings we hold, the period runs from 2021-06-09 to 2025-06-12, with EUR 37445 of purchases and EUR 0 of sales, and the filings concern Atara Biotherapeutics, Inc., Mirati Therapeutics, Inc. and Certara, Inc.
